MedTrace Logo

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

NCT07543367 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-05-11

No results posted yet for this study

Summary

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

Conditions

  • Neurological Disorder
  • ALS (Amyotrophic Lateral Sclerosis)
  • Motor Neuron Disease
  • ALS - Amyotrophic Lateral Sclerosis
  • ALS

Interventions

DEVICE

Stentrode

The Stentrode is an endovascular electrode array that senses electrical signals from the sensorimotor cortices.

Sponsors & Collaborators

  • Synchron, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2027-06-30
Completion
2029-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07543367 on ClinicalTrials.gov